MAPT and Alzheimer disease: The docking studies indicatethat CBD2115, PBB3, and PMPBB3 exhibit higher binding probabilities and affinities for many surfacesites in PSP tau than other tracers, in contrast to the stronger bindingfor the concave sites on AD tau fibrils.